# Comparison of Insulin Mix25 Versus Mix50

> **NCT01773473** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 403 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin Lispro Mix25
- **DRUG:** Insulin Lispro Mix50

## Key facts

- **NCT ID:** NCT01773473
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 403 (ACTUAL)
- **Last updated:** 2015-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01773473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01773473, "Comparison of Insulin Mix25 Versus Mix50". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01773473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*